Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability (Q37165739)

18 August 2017

Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability (English)

1 reference

18 August 2017

1 reference

3

Gennaro Bussone

1 reference

18 August 2017

2

Licia Grazzi

1 reference

18 August 2017

1

Domenico D'Amico

1 reference

PMC publication ID

2671823

18 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Neuropsychiatric Disease and Treatment

18 August 2017

1 reference

18 August 2017

2

1 reference

18 August 2017

3

1 reference

18 August 2017

261-267

1 reference

Practical use of topiramate for migraine prevention

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

6 September 2017

Migraine pathophysiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate monotherapy in epilepsy and migraine prevention

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

The International Classification of Headache Disorders: 2nd edition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate-associated acute, bilateral, secondary angle-closure glaucoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Global trends in migraine care: results from the MAZE survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Impact of migraine and migraine therapy on productivity and quality of life

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

The prevalence and characteristics of migraine in a population-based cohort: the GEM study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate improves health-related quality of life when used to prevent migraine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate in migraine prevention: results of a large controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Topiramate for migraine prevention: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Migraine headache disability and health-related quality-of-life: a population-based case-control study from England.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

New guidelines for the management of migraine in primary care.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

The impact of migraine on quality of life in the general population: the GEM study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Healthcare resource and lost labour costs of migraine headache in the US.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Migraine and reduced work performance: a population-based diary study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

3 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

3 September 2018

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Migraine patients experience poorer subjective well-being/quality of life even between attacks

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671823

Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine

3 September 2018

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Workplace disability in migraine: an Italian experience

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

The impact of migraine on work, family, and leisure among young women – a multinational study

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

The impact of migraine on psychological well-being of young women and their communication with physicians about migraine: a multinational study

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Effects of speaking rate on temporal patterns of English

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Guidelines for controlled trials of drugs in migraine: second edition

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPs

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Valproate-induced hyperammonemic encephalopathy in the presence of topiramate

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.3.261

Prevalence and clinical characteristics of migraine in France

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19412473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/NEDT.2006.2.3.261

1 reference

18 August 2017

1 reference

PMC publication ID

2671823

18 August 2017

PubMed publication ID

19412473

1 reference

PMC publication ID

2671823